CRAIG HILTS represents domestic and international companies in a wide range of capital markets, securities, public company reporting, and disclosure and corporate governance matters, with a particular emphasis on the life sciences and technology industries. Craig also frequently represents investment banks in capital markets transactions in the life sciences and technology sectors.
He has successfully represented clients in a wide range of complex capital markets transactions, including numerous initial public offerings, follow-on equity offerings, PIPEs, at-the-market offerings, senior debt offerings, convertible debt offerings, and liability management transactions.
Craig serves as principal outside counsel for many life sciences companies in which he provides strategic advice to boards of directors and management teams regarding significant transactions and public company obligations. Craig was named a 2021 “Top Rising Star” by The Deal.